Alaunos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Alaunos Therapeutics, Inc. (TCRT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $4.40 per share as of 2016-12-31, per its 10-K filed 2017-02-16.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2017-02-16
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.40.
- 2016-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.25.
- 2016-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $5.08.
- 2016-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.29.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2016-12-31 | $4.40 10-K · filed 2017-02-16 |
| 2016-09-30 | $4.25 10-Q · filed 2016-11-09 |
| 2016-06-30 | $5.08 10-Q · filed 2016-08-09 |
| 2016-03-31 | $4.29 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.24 10-K · filed 2016-02-24 |
| 2015-09-30 | $4.09 10-Q · filed 2015-11-02 |
| 2015-06-30 | $4.12 10-Q · filed 2015-08-10 |
| 2015-03-31 | $4.08 10-Q · filed 2015-05-07 |
| 2014-12-31 | $4.10 10-K · filed 2015-02-26 |
| 2014-09-30 | $4.12 10-Q · filed 2014-10-30 |
| 2014-06-30 | $4.11 10-Q · filed 2014-08-07 |
| 2014-03-31 | $4.28 10-Q · filed 2014-05-08 |
| 2013-12-31 | $4.01 10-K · filed 2014-03-03 |
| 2013-09-30 | $3.95 10-Q · filed 2013-10-22 |
| 2013-06-30 | $3.85 10-Q · filed 2013-08-08 |
| 2013-03-31 | $3.85 10-Q · filed 2013-05-07 |
| 2012-12-31 | $3.56 10-K · filed 2013-03-18 |
| 2012-09-30 | $4.09 10-Q · filed 2012-11-08 |
| 2012-06-30 | $4.10 10-Q/A · filed 2012-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |